The Stock Trader Hub Zee
@TSTHZeeVP of The Stock Trader Hub | Full-time day trader focusing on small caps |Click the link in bio for insights and free plays | Not a financial advisor
Similar User
@Disrupttech2
@hedgopia
@GMOInsights
@VertiCallAlgo
@thudderwicks
@KMTrading_SMC
@Spocksstocks
@RiskConqueror
@OptionsbyAshley
@TheSTRATalorian
@pmony5
@stockbeep
@BirdLaw_trading
@OryoJohn
@DipFinding
🚨 TSTH THANKSGIVING GIVEAWAY! 🚨 🎁 Prizes : 2 x iPads with Lifetime access to TSTH Buy/Sell Indicator 10 x Exclusive TSTH Hoodies 3 x $100 Cash TO ENTER : 1️⃣ Like & Retweet this post 2️⃣ Follow : @StockTraderHub @RockyTSTH @TSTHZee 👈🏻 3️⃣ Follow us on Instagram :…
Telsey Advisory Group Maintains Outperform on Abercrombie & Fitch, Maintains $190 Price Target $ANF
RBC Capital Maintains Sector Perform on Exxon Mobil, Lowers Price Target to $115 $XOM
RBC Capital Maintains Sector Perform on Old National, Raises Price Target to $25 $ONB
UBS Maintains Buy on Woodward, Raises Price Target to $228 $WWD
Citigroup Maintains Buy on American Airlines Gr, Raises Price Target to $19 $AAL
MoffettNathanson Maintains Neutral on Shopify, Raises Price Target to $99 $SHOP
Maxim Group Initiates Coverage On OS Therapies with Buy Rating, Announces Price Target of $8 $OSTX
Craig-Hallum Maintains Buy on Semtech, Raises Price Target to $70 $SMTC
Lexaria Bioscience Provides Strategic Update; Says Semaglutide Being Investigated For Applications In Heart Disease, Alzheimer’s, Liver Disease, And More; GLP-1 Drugs Expected To Generate Multi-Hundreds Of Billions Of Revenues In The... $LEXX
HC Wainwright & Co. Downgrades Poseida Therapeutics to Neutral, Lowers Price Target to $9 $PSTX
Northland Capital Markets Maintains Outperform on Similarweb, Raises Price Target to $17 $SMWB
Northland Capital Markets Maintains Outperform on Semtech, Raises Price Target to $60 $SMTC
Cognition Therapeutics Announces Completion of Final Visits In Phase 2 SHIMMER Study Of CT1812 For Dementia With Lewy Bodies $CGTX
Needham Reiterates Buy on Blue Bird, Announces $66 Price Target $BLBD
Arrowhead Pharmaceuticals And Sarepta Therapeutics Enter Global License And Collaboration Deal For Genetic Disease Programs $ARRW
$ENPH was rejected at the 21 EMA resistance, but the MACD is signaling a bullish trend . If the price breaks above this resistance, the next level to watch is $76.20, with a gap between $78 and $84. However, if it fails to break the 21 EMA resistance, the support level to monitor…
Guggenheim Reiterates Buy on NEXTracker, Maintains $55 Price Target $NXT
Morgan Stanley Maintains Overweight on Vistra, Raises Price Target to $169 $VST
United States Trends
- 1. #twug 3.194 posts
- 2. #RTXOn 5.845 posts
- 3. $ELONIA 1.543 posts
- 4. Thankful 62,9 B posts
- 5. Happy Thanksgiving 26,8 B posts
- 6. Sharon Stone 1.607 posts
- 7. #PMSLive 2.339 posts
- 8. Johnie Cooks N/A
- 9. Hezbollah 150 B posts
- 10. #PumpRules 3.456 posts
- 11. Lebanon 182 B posts
- 12. Mack Brown 4.917 posts
- 13. #ai16z 2.426 posts
- 14. Rivian 8.568 posts
- 15. $CUTO 7.423 posts
- 16. James Houston N/A
- 17. $BULLY 4.333 posts
- 18. Billboard 569 B posts
- 19. Broyles Award N/A
- 20. Martinelli 7.368 posts
Who to follow
-
Disruptive Technology
@Disrupttech2 -
hedgopia
@hedgopia -
GMO
@GMOInsights -
VertiCall Trading
@VertiCallAlgo -
NOTRELOAD AI
@thudderwicks -
KM Trading
@KMTrading_SMC -
Stockman
@Spocksstocks -
RiskConqueror
@RiskConqueror -
OptionsByAshley
@OptionsbyAshley -
DISCIPLINE OVER DOLLAR$
@TheSTRATalorian -
Pmony
@pmony5 -
Stockbeep
@stockbeep -
BirdLaw Trading
@BirdLaw_trading -
oryo
@OryoJohn -
Finding the Dip
@DipFinding
Something went wrong.
Something went wrong.